Omar Galdame

625 total citations
39 papers, 450 citations indexed

About

Omar Galdame is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Omar Galdame has authored 39 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 30 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Omar Galdame's work include Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis B Virus Studies (19 papers). Omar Galdame is often cited by papers focused on Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis B Virus Studies (19 papers). Omar Galdame collaborates with scholars based in Argentina, Cuba and Australia. Omar Galdame's co-authors include Adrián Gadano, Sebastián Marciano, Hugo Fainboim, Alberto Muñoz, Paola Casciato, Eduardo Müllen, María Victoria Preciado, Natalia Paladino, Pamela Valva and Leonardo Fainboim and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Omar Galdame

39 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Galdame Argentina 14 336 332 53 49 37 39 450
Hamad I. Al‐Ashgar Saudi Arabia 16 365 1.1× 396 1.2× 71 1.3× 81 1.7× 40 1.1× 40 571
R Heyne Germany 15 552 1.6× 586 1.8× 41 0.8× 27 0.6× 24 0.6× 59 673
Montserrat Maldonado‐González Mexico 11 305 0.9× 332 1.0× 10 0.2× 19 0.4× 37 1.0× 26 432
Santa Brancatelli Italy 14 370 1.1× 382 1.2× 22 0.4× 15 0.3× 27 0.7× 22 477
Koichi Kanai Japan 12 249 0.7× 245 0.7× 32 0.6× 89 1.8× 52 1.4× 43 452
Yen‐Cheng Chiu Taiwan 13 211 0.6× 213 0.6× 38 0.7× 72 1.5× 40 1.1× 36 367
Zhihong Wan China 16 221 0.7× 213 0.6× 56 1.1× 62 1.3× 87 2.4× 30 482
Katsutaro Hirota Japan 10 382 1.1× 439 1.3× 105 2.0× 29 0.6× 27 0.7× 13 576
Shiro Fukumoto Japan 10 227 0.7× 209 0.6× 67 1.3× 46 0.9× 34 0.9× 27 372
C. G. Mitchell United Kingdom 7 270 0.8× 280 0.8× 26 0.5× 98 2.0× 24 0.6× 11 412

Countries citing papers authored by Omar Galdame

Since Specialization
Citations

This map shows the geographic impact of Omar Galdame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Galdame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Galdame more than expected).

Fields of papers citing papers by Omar Galdame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Galdame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Galdame. The network helps show where Omar Galdame may publish in the future.

Co-authorship network of co-authors of Omar Galdame

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Galdame. A scholar is included among the top collaborators of Omar Galdame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Galdame. Omar Galdame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ridruejo, Ezequiel, et al.. (2019). Recomendaciones para el tratamiento de la Hepatitis Crónica por Virus C en pacientes con insuficiencia renal crónica, en diálisis o trasplantados renales. Indicaciones de tratamiento 2018. Redalyc (Universidad Autónoma del Estado de México). 39(1). 55–72. 1 indexed citations
2.
Marciano, Sebastián, Leila Haddad, Mirta Peralta, et al.. (2018). Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study. Journal of Medical Virology. 90(5). 951–958. 14 indexed citations
3.
Valva, Pamela, Paola Casciato, María Soledad Caldirola, et al.. (2017). Chronic hepatitis C liver microenvironment: role of the Th17/Treg interplay related to fibrogenesis. Scientific Reports. 7(1). 13283–13283. 16 indexed citations
4.
Lello, Federico A. Di, Eduardo Müllen, Omar Galdame, et al.. (2016). Compartmentalization of hepatitis C virus variants in patients with hepatocellular carcinoma. Molecular Carcinogenesis. 56(2). 371–380. 3 indexed citations
5.
Torres, Carolina, Ina Sevic, María Mora González López Ledesma, et al.. (2016). Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina. PLoS ONE. 11(7). e0159509–e0159509. 13 indexed citations
6.
Torres, Carolina, et al.. (2015). Identification of a new clade of hepatitis B virus genotype F. Infection Genetics and Evolution. 34. 122–125. 3 indexed citations
7.
Ridruejo, Ezequiel, Sebastián Marciano, Omar Galdame, et al.. (2014). Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice. Annals of Hepatology. 13(3). 327–336. 9 indexed citations
8.
Valva, Pamela, María Inés Gismondi, Paola Casciato, et al.. (2014). Distinctive intrahepatic characteristics of paediatric and adult pathogenesis of chronic hepatitis C infection. Clinical Microbiology and Infection. 20(12). O998–O1009. 10 indexed citations
9.
Gadano, Adrián, Luis Gaite, Sebastián Marciano, & Omar Galdame. (2014). Hepatitis C in Argentina: epidemiology and treatment. PubMed. 6. 35–35. 9 indexed citations
11.
Valva, Pamela, Paola Casciato, Marcela Galoppo, et al.. (2013). Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children. PLoS ONE. 8(1). e53519–e53519. 24 indexed citations
12.
Ridruejo, Ezequiel, Sebastián Marciano, Oscar G. Mandό, et al.. (2011). 1177 INTERLEUKIN-28B PREDICTS SVR IN LATIN AMERICAN HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH PEG IFN AND RIBAVIRIN. Journal of Hepatology. 54. S465–S465. 1 indexed citations
13.
Valva, Pamela, Paola Casciato, Juan María Díaz Carrasco, et al.. (2011). The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection. PLoS ONE. 6(8). e23218–e23218. 43 indexed citations
14.
Ledesma, María Mora González López, Omar Galdame, Hugo Fainboim, et al.. (2011). Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus. International Journal of Infectious Diseases. 15(5). e314–e320. 17 indexed citations
15.
Bandi, Juan Carlos, et al.. (2010). 841 LONG TERM FOLLOW UP OF PATIENTS TREATED WITH COATED STENTS TIPS. Journal of Hepatology. 52. S328–S328. 3 indexed citations
16.
Gadano, Adrián, Omar Galdame, & Sebastián Marciano. (2010). Diagnosis of patients with suspected chronic hepatitis C infection. Annals of Hepatology. 9. S34–S38. 5 indexed citations
17.
Paladino, Natalia, Hugo Fainboim, Alberto Muñoz, et al.. (2006). Gender Susceptibility to Chronic Hepatitis C Virus Infection Associated with Interleukin 10 Promoter Polymorphism. Journal of Virology. 80(18). 9144–9150. 77 indexed citations
18.
Villamil, Alejandra, et al.. (2005). Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases. The American Journal of Medicine. 118(10). 1160–1163. 27 indexed citations
19.
Bandi, Juan Carlos, et al.. (2004). 556 Overlap syndrome PBC/AIH: Prevalence, long term evolution and prognostic factors. Journal of Hepatology. 40. 163–163. 4 indexed citations
20.
Heras, M. De las, Raquel Abecasis, Rubén Terg, et al.. (1997). Daily Variation in Portal Blood Flow and the Effect of Propranolol Administration in A Randomized Study of Patients With Cirrhosis. Hepatology. 25(3). 548–550. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026